Literature DB >> 8878782

Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis.

M Gassó1, M Rubio, G Varela, M Cabré, J Caballería, E Alonso, R Deulofem, J Camps, A Giménez, M Pajares, A Parés, J M Mato, J Rodés.   

Abstract

BACKGROUND/AIM: The aim of this study was to investigate the effects of S-adenosylmethionine on liver peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis.
METHODS: Cirrhosis was induced in three groups of six rats by repeated injections of carbon tetrachloride over 9 weeks. One group of animals was treated only with carbon tetrachloride, and the other two received carbon tetrachloride plus S-adenosylmethionine (10 mg/kg intramuscularly daily) from week 3 to week 9, and from week 6 to week 9 of the study, respectively. Two additional groups of six rats, a control group and a group treated only with S-adenosylmethionine, were also studied. Glutathione concentration, thiobarbituric acid-reactive substances, collagen content, prolyl hydroxylase activity, and procollagen type I mRNA expression were determined in liver samples.
RESULTS: All carbon tetrachloride-treated rats had cirrhosis at the end of the study. Cirrhosis was also present in five of the six carbon tetrachloride-treated rats receiving S-adenosylmethionine for 3 weeks, but in only one of the six rats that received S-adenosylmethionine for 6 weeks. Hepatic glutathione was significantly diminished in carbon tetrachloride-treated rats (2.7 +/- 0.3 mumol/g tissue) and returned to normal in rats receiving S-adenosylmethionine for 3 or 6 weeks (3.7 +/- 0.13 and 3.9 +/- 0.11 mumol/g tissue, respectively). The hepatic thiobarbituric acid-reactive substances were significantly lower in rats treated with carbon tetrachloride and S-adenosylmethionine for 6 weeks (98 +/- 5 nmol/g) than in rats treated with carbon tetrachloride (134 +/- 12 nmol/g) and in those treated with carbon tetrachloride and S-adenosylmethionine for 3 weeks (127 +/- 13 nmol/g). There were no differences in either hepatic collagen and prolyl hydroxylase activity between rats that received only carbon tetrachloride and those treated with S-adenosylmethionine for 3 weeks. In contrast, carbon tetrachloride-treated rats receiving S-adenosylmethionine for 6 weeks had significantly lower collagen and prolyl hydroxylase activity than the other two groups. A much greater increase in procollagen type I mRNA was found in carbon tetrachloride-treated rats than in rats treated with carbon tetrachloride and S-adenosylmethionine for 6 weeks. Furthermore, there was a significant correlation between the hepatic thiobarbituric acid-reactive substances and prolyl hydroxylase activity and hepatic collagen.
CONCLUSIONS: We conclude that the early administration of S-adenosylmethionine in a model of carbon tetrachloride-induced liver injury restores glutathione levels and reduces lipid peroxidation, resulting in less advanced liver fibrosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878782     DOI: 10.1016/s0168-8278(96)80074-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  24 in total

1.  Protective actions of salvianolic acid A on hepatocyte injured by peroxidation in vitro.

Authors:  Yi-Yang Hu; Cheng-Hai Liu; Run-Ping Wang; Cheng Liu; Ping Liu; Da-Yuang Zhu
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

2.  Hepatic production of apolar aldehydes in rats with carbon tetrachloride-induced cirrhosis.

Authors:  N Ferré; J Girona; M Cabré; J Joven; A LaVille; L Masana; J L Paternáin; J Camps
Journal:  Mol Cell Biochem       Date:  1999-08       Impact factor: 3.396

Review 3.  Hepatoprotective effects of S-adenosyl-L-methionine against alcohol- and cytochrome P450 2E1-induced liver injury.

Authors:  Arthur I Cederbaum
Journal:  World J Gastroenterol       Date:  2010-03-21       Impact factor: 5.742

4.  Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment.

Authors:  Judit Marsillach; Gerard Aragonès; Bharti Mackness; Michael Mackness; Anna Rull; Raúl Beltrán-Debón; Juan Pedro-Botet; Carlos Alonso-Villaverde; Jorge Joven; Jordi Camps
Journal:  Lipids Health Dis       Date:  2010-05-14       Impact factor: 3.876

5.  The multifaceted role of pirfenidone and its novel targets.

Authors:  José Macías-Barragán; Ana Sandoval-Rodríguez; Jose Navarro-Partida; Juan Armendáriz-Borunda
Journal:  Fibrogenesis Tissue Repair       Date:  2010-09-01

6.  Investigation of the hepatoprotective effects of Sesame (Sesamum indicum L.) in carbon tetrachloride-induced liver toxicity.

Authors:  Nureddin Cengiz; Servet Kavak; Ali Güzel; Hanefi Ozbek; Hava Bektaş; Aydın Him; Ender Erdoğan; Ragıb Balahoroğlu
Journal:  J Membr Biol       Date:  2012-08-23       Impact factor: 1.843

7.  Hepatoprotective effect of infliximab, an anti-TNF-alpha agent, on carbon tetrachloride-induced hepatic fibrosis.

Authors:  Ibrahim Halil Bahcecioglu; Suleyman Serdar Koca; Orhan Kursat Poyrazoglu; Mehmet Yalniz; Ibrahim Hanifi Ozercan; Bilal Ustundag; Kazim Sahin; Adile Ferda Dagli; Ahmet Isik
Journal:  Inflammation       Date:  2008-04-22       Impact factor: 4.092

8.  Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis.

Authors:  Amalia Pavanato; María J Tuñón; Sonia Sánchez-Campos; Claudio A Marroni; Susana Llesuy; Javier González-Gallego; Norma Marroni
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

9.  Effect of ATRA on contents of liver retinoids, oxidative stress and hepatic injury in rat model of extrahepatic cholestasis.

Authors:  Haiyan Jiang; Zili Dan; Hui Wang; Jusheng Lin
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2007-10

10.  Comparison of S-adenosyl-L-methionine (SAMe) and N-acetylcysteine (NAC) protective effects on hepatic damage when administered after acetaminophen overdose.

Authors:  Marcus V Terneus; J Michael Brown; A Betts Carpenter; Monica A Valentovic
Journal:  Toxicology       Date:  2007-11-07       Impact factor: 4.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.